Showing results (2111-2120 of 2,589) with videos related to

Sort By:
Pageof 259
Molecular Oncology|September 30, 2022
Dynamic monitoring of PD-L1 and Ki67 in circulating tumor cells of metastatic non-small cell lung cancer patients treated with pembrolizumabMaria Spiliotaki, Christiana Michael Neophytou, Paris Vogazianos, et al.
Molecular Oncology|October 9, 2022
The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancerJian Pan, Jinou Zhao, Xudong Ni, et al.
Molecular Oncology|October 10, 2022
MYC and therapy resistance in cancer: risks and opportunitiesGiulio Donati, Bruno Amati
Molecular Oncology|October 11, 2022
Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TRα1, in intestinal lesionsMaria Virginia Giolito, Théo La Rosa, Diana Farhat, et al.
Molecular Oncology|February 13, 2021
DNA methylation markers have universal prognostic value for anal cancer risk in HIV-negative and HIV-positive individualsRamon P van der Zee, Carel J M van Noesel, Ivonne Martin, et al.
Molecular Oncology|March 2, 2021
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatmentEmmy Boerrigter, Guillemette E Benoist, Inge M van Oort, et al.
Molecular Oncology|March 11, 2021
A novel cell-free DNA methylation-based model improves the early detection of colorectal cancerXianrui Wu, Yunfeng Zhang, Tuo Hu, et al.
Molecular Oncology|October 4, 2019
MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitinationDong-Kyu Chae, Jinyoung Park, Moonsoo Cho, et al.
Molecular Oncology|October 5, 2019
Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancerGustav Steinemann, Alexandra Dittmer, Jacob Schmidt, et al.
Molecular Oncology|August 29, 2022
Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcomaAlexander R Kovach, Kristianne M Oristian, David G Kirsch, et al.
Pageof 259